Evidence map›Paper›PMID 34402038›Full record

ArticleJournal of medical toxicology : official journal of the American College of Medical Toxicology2021

"Waste Not, Want Not" - Leveraging Sewer Systems and Wastewater-Based Epidemiology for Drug Use Trends and Pharmaceutical Monitoring.

Timothy B Erickson, Noriko Endo, Claire Duvallet, Newsha Ghaeli, Kaitlyn Hess, Eric J Alm, Mariana Matus, Peter R Chai

Abstract read
In one paragraph

Article in Journal of medical toxicology : official journal of the American College of Medical Toxicology, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 17 papers.

0numbers the graph read from it
0cells of the map it votes in
17citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

17 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Review
  5. Review
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Review
  15. Review
  16. Review
  17. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Timothy B EricksonDepartment of Emergency Medicine / Division of Toxicology, Brigham & Women's Hospital / Harvard Medical School, 10 Vining St, Boston, MA, 02155, USA. terickson@bwh.harvard.edu.ORCID 0000-0002-1809-4805
Noriko EndoBiobot Analytics, Inc., Cambridge, MA, USA.
Claire DuvalletBiobot Analytics, Inc., Cambridge, MA, USA.
Newsha GhaeliBiobot Analytics, Inc., Cambridge, MA, USA.
Kaitlyn HessBiobot Analytics, Inc., Cambridge, MA, USA.
Eric J AlmDepartment of Biological Engineering, Massachusetts Institute of Technology, Cambridge, MA, USA.
Mariana MatusBiobot Analytics, Inc., Cambridge, MA, USA.
Peter R ChaiDepartment of Emergency Medicine / Division of Toxicology, Brigham & Women's Hospital / Harvard Medical School, 10 Vining St, Boston, MA, 02155, USA.

Funding

A novel robotic wastewater analysis system to quantify opioid exposure and treatment in residential communitiesR44DA051106 · NIDA · BIOBOT ANALYTICS, INC. · PI CHAI, PETER R, MATUS GARCIA, MARIANA G · 2020 to 2022
$1.5M
Development of Ingestible Biosensors to Enhance PrEP Adherence in Substance UsersK23DA044874 · NIDA · BRIGHAM AND WOMEN'S HOSPITAL · PI CHAI, PETER R · 2018 to 2022
$1.0M
NIDA NIH HHS 1 R44 DA051106-01NIDA NIH HHS K23 DA044874NIDA NIH HHS R44 DA051106NIH HHS K23DA044874
6 · The paper itself

Abstract

During the current global COVID-19 pandemic and opioid epidemic, wastewater-based epidemiology (WBE) has emerged as a powerful tool for monitoring public health trends by analysis of biomarkers including drugs, chemicals, and pathogens. Wastewater surveillance downstream at wastewater treatment plants provides large-scale population and regional-scale aggregation while upstream surveillance monitors locations at the neighborhood level with more precise geographic analysis. WBE can provide insights into dynamic drug consumption trends as well as environmental and toxicological contaminants. Applications of WBE include monitoring policy changes with cannabinoid legalization, tracking emerging illicit drugs, and early warning systems for potent fentanyl analogues along with the resurging wave of stimulants (e.g., methamphetamine, cocaine). Beyond drug consumption, WBE can also be used to monitor pharmaceuticals and their metabolites, including antidepressants and antipsychotics. In this manuscript, we describe the basic tenets and techniques of WBE, review its current application among drugs of abuse, and propose methods to scale and develop both monitoring and early warning systems with respect to measurement of illicit drugs and pharmaceuticals. We propose new frontiers in toxicological research with wastewater surveillance including assessment of medication assisted treatment of opioid use disorder (e.g., buprenorphine, methadone) in the context of other social burdens like COVID-19 disease.

Indexed as

Wastewater-Based Epidemiological MonitoringBiomarkersCOVID-19HumansIllicit DrugsPandemicsPharmaceutical PreparationsSARS-CoV-2Substance Abuse DetectionSubstance-Related DisordersWastewaterWater Pollutants, ChemicalBiomarkersIllicit DrugsPharmaceutical PreparationsWastewaterWater Pollutants, ChemicalOpioidsSewersStimulantsSurveillanceWastewater

Identifiers

PMID34402038
PMCPMC8366482

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.